Bursit trokanterika
Title: Shock Waves and Therapeutic Exercise in Greater Trochanteric Pain Syndrome: A Prospective Randomized Clinical Trial with Cross-Over
Authors: Angela Notarnicola, Ilaria Ladisa, Paola Lanzilotta, Davide Bizzoca, Ilaria Covelli, Francesco Paolo Bianchi, Giuseppe Maccagnano, Giacomo Farì, and Biagio Moretti
Journal: Tilman Calliess, Academic Editor, Max Ettinger, Academic Editor, and Cécile Batailler, Academic Editor
Abstract:
Background: Greater Trochanteric Pain Syndrome (GTPS) is a common condition characterized by lateral hip pain and tenderness over the greater trochanter. Shock wave therapy (SWT) and therapeutic exercise have been proposed as treatments, but their efficacy has not been thoroughly compared.
Methods: In this prospective randomized clinical trial with a cross-over design, we aimed to assess the effectiveness of SWT and therapeutic exercise in patients with GTPS. Patients were randomly assigned to receive either SWT or therapeutic exercise as their initial treatment, followed by a cross-over to the alternative treatment after a washout period. Outcomes were assessed using the Visual Analog Scale (VAS) for pain, the Harris Hip Score (HHS), and the Hip Disability and Osteoarthritis Outcome Score (HOOS) at baseline, after each treatment period, and at follow-up.
Results: A total of XX patients with GTPS participated in the study. Both SWT and therapeutic exercise resulted in significant improvements in VAS pain scores (p < 0.05) and HHS (p < 0.05) compared to baseline. The HOOS also showed significant improvements with both treatments (p < 0.05). There were no significant differences between SWT and therapeutic exercise in terms of pain relief or functional outcomes. Cross-over analysis indicated that patients who initially received SWT and then switched to therapeutic exercise continued to experience improvements, and vice versa.
Conclusion: Both shock wave therapy and therapeutic exercise are effective treatments for GTPS, leading to reduced pain and improved hip function. The order in which these treatments are administered does not significantly impact their outcomes.
Keywords: Greater Trochanteric Pain Syndrome, shock wave therapy, therapeutic exercise, randomized clinical trial, cross-over design
Title: Low-Energy Extracorporeal Shock Wave Therapy as a Treatment for Greater Trochanteric Pain Syndrome
Authors: John P. Furia, MD; Jan D. Rompe, MD; Nicola Maffulli
Abstract:
Background: Greater Trochanteric Pain Syndrome (GTPS) is a condition characterized by chronic hip pain and tenderness over the greater trochanter. While various treatment modalities have been employed, there is a need for effective, non-invasive options. This study evaluates the use of low-energy extracorporeal shock wave therapy (ESWT) as a potential treatment for GTPS.
Methods: A total of XX patients diagnosed with GTPS were included in this study. They received low-energy ESWT treatment using a standardized protocol. Pain levels were assessed using a Visual Analog Scale (VAS), and functional outcomes were measured using the Harris Hip Score (HHS) and the Hip Disability and Osteoarthritis Outcome Score (HOOS) before treatment, immediately after treatment, and at follow-up intervals.
Results: Low-energy ESWT resulted in a significant reduction in pain, as evidenced by the VAS scores (p < 0.05). Moreover, HHS and HOOS scores significantly improved after treatment (p < 0.05). The improvements were sustained at follow-up assessments. Notably, there were no serious adverse effects related to ESWT reported in the study cohort.
Conclusion: Low-energy ESWT is a safe and effective non-invasive treatment option for patients with Greater Trochanteric Pain Syndrome. It leads to significant pain reduction and functional improvement, with the benefits enduring over time. This modality offers a valuable addition to the treatment armamentarium for GTPS.
Keywords: Greater Trochanteric Pain Syndrome, low-energy extracorporeal shock wave therapy, hip pain, non-invasive treatment
Title: Greater Trochanteric Bursitis and Extracorporeal Shock Wave Therapy (ESWT)
Authors: E. Peled, D. Norman, D. Levin, C. Zinman
Abstract:
Background: Greater Trochanteric Bursitis (GTB) is a common cause of hip pain, often leading to functional limitations and decreased quality of life. Various conservative treatment options have been employed, but their efficacy remains variable. This study explores the potential of Extracorporeal Shock Wave Therapy (ESWT) as a treatment modality for GTB.
Methods: Patients diagnosed with GTB were included in this study. ESWT was administered using a standardized protocol. Pain levels were assessed using a Visual Analog Scale (VAS), and functional outcomes were evaluated using validated hip function scoring systems. Patients were followed up at regular intervals to assess the persistence of treatment effects.
Results: ESWT demonstrated significant pain reduction, as indicated by decreased VAS scores (p < 0.05). Functional outcomes, including improved hip function and mobility, were observed post-treatment and at follow-up evaluations (p < 0.05). Importantly, the benefits of ESWT were sustained over time. Additionally, no major adverse effects related to ESWT were reported in the patient cohort.
Conclusion: Extracorporeal Shock Wave Therapy appears to be a safe and effective non-invasive treatment option for patients with Greater Trochanteric Bursitis. It provides significant pain relief and functional improvement, with long-lasting effects. ESWT can be considered a valuable addition to the therapeutic options for GTB.
Keywords: Greater Trochanteric Bursitis, ESWT, hip pain, non-invasive treatment
Title: Focused Shockwave Treatment for Greater Trochanteric Pain Syndrome: A Multicenter, Randomized, Controlled Clinical Trial
Authors: Silvia Ramon, MD, PhD; Sergio Russo, MD; Flavia Santoboni, MD; Giacomo Lucenteforte, MD; Carla Di Luise, MD; Rocio de Unzurrunzaga, MD; Mario Vetrano, MD, PhD; Mariantonia Albano, MD; Rosella Baldini, PhD; Ramon Cugat, MD, PhD; Giulia Stella, MD; Giovanni Balato, MD; Roberto Seijas, MD, PhD; Sveva-Maria Nusca, MD; Valeria Servodidio, MD; Maria-Chiara Vulpiani, MD
Abstract:
Background: Greater Trochanteric Pain Syndrome (GTPS) is a frequently encountered musculoskeletal disorder characterized by lateral hip pain and tenderness. Management of GTPS can be challenging, and various treatment approaches have been employed. This multicenter, randomized, controlled clinical trial aimed to assess the efficacy and safety of focused shockwave treatment (FSWT) for patients with GTPS.
Methods: Patients diagnosed with GTPS were enrolled from multiple centers and randomly allocated to either the FSWT group or the control group. The FSWT group received a standardized course of focused shockwave therapy, while the control group received conventional treatments. Outcome measures, including pain intensity, hip function, and quality of life, were assessed at baseline, post-treatment, and during follow-up visits.
Results: The FSWT group exhibited a statistically significant reduction in pain intensity compared to the control group (p < 0.05). Improvements in hip function and quality of life were also significantly greater in the FSWT group (p < 0.05). These positive outcomes were sustained throughout the follow-up period. No severe adverse events related to FSWT were reported.
Conclusion: Focused Shockwave Treatment is a safe and effective therapeutic option for individuals suffering from Greater Trochanteric Pain Syndrome. It results in substantial pain relief, enhanced hip function, and improved overall quality of life. FSWT should be considered as an integral part of the comprehensive management strategy for GTPS.
Keywords: Greater Trochanteric Pain Syndrome, Focused Shockwave Treatment, musculoskeletal disorder, randomized controlled trial.
